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CONCLUSIONS
This study brings to light the success of valve-sparing
aortic procedures in patients with aortopathies and high-
lights the need for further investigation to determine the
valve-sparing technique that will afford the best long-term
durability. This study also underscores the extent of aortic
pathology in patients with these syndromes, especially
LDS, and substantiates the importance of continued surveil-
lance for aortic aneurysm and dissection beyond the ascend-
ing graft, as well as the need for studies to assess the benefit
of medical therapies preoperatively and postoperatively in
these patients.
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Dr Anees J. Razzouk (Loma Linda, Calif). Congratulations on
a nice presentation. Ivan Rebeyka regrets not being here this morn-
ing. I will be reading his comments and asking you his questions.
The authors are to be applauded for their initiative in combining
the experience from separate centers in Salt Lake City and Denver
to provide us with important information in the management of
children with Marfan and Marfan-like syndromes. The essence of
their data relates to the 30 patients who underwent aortic root sur-
gery at a mean age of 14 years and in whom 21 had a valve-sparing
procedure compared to 9 having a composite replacement or a Ben-
tall-type procedure. The two most important surgical decisions re-
quired in this group of patients is when to operate and if so what
operation to perform. While it is difficult to argue with reasonably
well established and accepted indications for surgery based on an
aortic size greater than 45 to 50 mm, the decision to operate be-
comes more challenging when younger and smaller patients present
with large ascending aortas relative to their body size but less than
45 mm in diameter. For example, a 2-year-old weighing 15 kg
might present with a 30-mm ascending aorta yet only to have
a valve annulus size of 16 mm. How do you decide if and when
such a patient should be advised to have an operation?
Dr Everitt. I think one of the most important things is to be sure
you have the diagnosis correct. In our paper, we did show that there
is a difference between patients with Marfan syndrome versus
Loeys-Dietz with respect to complications. Those patients, as pre-
viously published, were more likely to have dissection and death
due to dissection. The published criteria which is what we follow
for Loeys-Dietz is Z-score, so if the Z-score is greater than or equal
to 3.5, we will operate at an aortic root size less than 45 mm, so
based on index to body surface area. There were patients who
were identified after 2005 who had an aortic root in the 30s that
did undergo the procedure. As far as those with Marfan syndrome,
we are still following the criteria of 50mm unless they have a family
history of dissection or the rapid growth. I agree that it is a chal-
lenge. I think the literature prior to 2005, much of the literature after
2005, and our experiences have heterogeneous patient population
and, like I said, it is important to know what type of aortic pathol-
ogy you are dealing with, not only to determine the size at which to
operate but also the extent of the operation because these patients
with Loeys-Dietz syndrome have aortic pathology beyond what
we standardly replace in Marfan syndrome. We follow the recom-
mendations to image the entire aorta preoperatively with MRI scan
as our method of choice and to follow them yearly withMRI scan to
look for further dissection. That was the cause of death. There were
four deaths in our paper and three deaths were due to dissection. All
three patients had Loeys-Dietz syndrome.
Dr Razzouk. My last question relates to your conclusion sup-
porting the success of valve-sparing techniques over compositergery c June 2009
Everitt et al Congenital Heart Disease
C
H
Daortic root replacement with mechanical valve in this patient pop-
ulation. More specifically, 4 out of 8 or 50% of patients undergoing
the remodeling technique had an adverse outcome defined by you
as need for reoperation, new aortic dissection, or death. Conversely,
only 1 of 12 or less than 10% of patients having the reimplantation
or David procedure experienced one of these issues. Accordingly, I
was wondering why you did not include the apparent superiority of
reimplantation procedure over remodeling as one of the study’s im-
portant messages.The Journal of Thoracic and CAgain, congratulations on your superb results and your very nice
presentation.
Dr Everitt. I did not want to make that statement too strongly
because our numbers were small and we did show a difference in
univariate analysis but not in multivariate analysis, so there may
be other confounding factors. I do think that it is very suggestive
that the reimplantation technique is superior but I think making de-
finitive conclusions are difficult with a small patient population, al-
beit one of the largest series to be published in children.ardiovascular Surgery c Volume 137, Number 6 1333
